跳至主要内容
临床试验/IRCT201512077676N4
IRCT201512077676N4已完成未知

The effect of progesterone in patients with premature rupture of membranes

Vice Chancellor for Research and Technology University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 48 years(—)
性别
Female

入选标准

  • pregnant women with gestational age between 26 to 32 weeks with premature rupture of membranes (PROM); signing informed consent.
  • Exclusion criteria: fetal abnormalities; genetic abnormalities that can affect fetal growth that have been checked by ultrasound at 18 to 20 weeks and 28 to 32 weeks. Along with trisomy screening marker with double or quad marker; precambrian patients; chronic high blood pressure; overt diabetes; pregnancy-related diabetes; detachment; prolapsed umbilical cord; chorioamnionitis; gestational age over 32 weeks (because there isn’t sufficient time to study the effects of progesterone); patient who have had a rupture of the membranes after 36 hours; patient who are in active phase.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research and Technology University of Medical Sciences

相似试验

The effect of progesterone in patients with... | 临床试验